Purpose: To compare the arterial enhancement of hypervascular hepatic lesions by T1-weighted 3D-GRE (gradientrecalled echo) fat-sat sequence after slow (0.5 mL/sec) and fast (2 mL/sec) RESOVIST infusion. Materials and Methods: We prospectively enrolled 71 patients with hypervascular hepatic lesions to undergo dynamic magnetic resonance imaging (MRI) examination with RESOVIST. A total of 92 benign and malignant lesions, 44 of which histologically confirmed, were examined. Three blinded and independent readers visually assessed the arterial enhancement using a score from 0 (none) to 3 (maximum), the latter score comparable to that achievable by MultiHance administration. Results: Out of the 92 hypervascular lesions, 41, 31, and 20 nodules were examined using the slow, fast, and both protocols, respectively. Relevant enhancement (scores 2–3) was found in 42% vs. 14.5% of cases for slow and fast protocols, respectively. Intraindividual comparison evaluation confirmed the better results obtained by slow than fast protocol (25% vs. 10%), with statistically relevant difference in distribution of scores (P 0.0004). The slow protocol showed values between 0 and 3 with an arithmetic mean of 1.1; the fast one, on the other hand, showed values between 0 and 2 with an arithmetic mean of 0.66. Conclusion: Slow infusion improves arterial enhancement after RESOVIST administration.
SPIO enhanced liver MRI with SHU 555 A (RESOVIST): new protocol infusion to improve arterial phase evaluation - a prospective study / L.Grazioli; M.Bondioni; L.Romanini; B.Frittoli; S.Gambarini; F.Donato; L.Santoro; S.Colagrande. - In: JOURNAL OF MAGNETIC RESONANCE IMAGING. - ISSN 1053-1807. - STAMPA. - 29:(2009), pp. 607-616. [10.1002/jmri.21644]
SPIO enhanced liver MRI with SHU 555 A (RESOVIST): new protocol infusion to improve arterial phase evaluation - a prospective study
COLAGRANDE, STEFANO
2009
Abstract
Purpose: To compare the arterial enhancement of hypervascular hepatic lesions by T1-weighted 3D-GRE (gradientrecalled echo) fat-sat sequence after slow (0.5 mL/sec) and fast (2 mL/sec) RESOVIST infusion. Materials and Methods: We prospectively enrolled 71 patients with hypervascular hepatic lesions to undergo dynamic magnetic resonance imaging (MRI) examination with RESOVIST. A total of 92 benign and malignant lesions, 44 of which histologically confirmed, were examined. Three blinded and independent readers visually assessed the arterial enhancement using a score from 0 (none) to 3 (maximum), the latter score comparable to that achievable by MultiHance administration. Results: Out of the 92 hypervascular lesions, 41, 31, and 20 nodules were examined using the slow, fast, and both protocols, respectively. Relevant enhancement (scores 2–3) was found in 42% vs. 14.5% of cases for slow and fast protocols, respectively. Intraindividual comparison evaluation confirmed the better results obtained by slow than fast protocol (25% vs. 10%), with statistically relevant difference in distribution of scores (P 0.0004). The slow protocol showed values between 0 and 3 with an arithmetic mean of 1.1; the fast one, on the other hand, showed values between 0 and 2 with an arithmetic mean of 0.66. Conclusion: Slow infusion improves arterial enhancement after RESOVIST administration.File | Dimensione | Formato | |
---|---|---|---|
48) JMRI Reso L vs V.pdf
accesso aperto
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Open Access
Dimensione
664.17 kB
Formato
Adobe PDF
|
664.17 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.